BIOMAT Database Logo BIOMAT Database Logo

Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps. 2006

Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Department of Plastic Surgery, Xijing Hospital Fourth Military Medical University, Xi'an, Shaanxi Province, China.

BACKGROUND Neovascularization occurs through two mechanisms: angiogenesis and vasculogenesis. Therefore, there are two strategies to promote neovascularization: therapeutic angiogenesis and therapeutic vasculogenesis (endothelial progenitor cells therapy). METHODS In this study, we examined whether or not endothelial progenitor cells combined with vascular endothelial growth factor (VEGF) gene therapy is useful for ischemia surgical flaps in vivo. At the same time, we quantitatively compared the neovascularization ability of transplanted endothelial progenitor cells (EPCs) transducted with VEGF165 gene and EPCs alone. EPCs were isolated from cord blood of healthy human volunteers, cultured in vitro for 7 days and identified by immunofluorescence. After transduced with VEGF165 gene in vitro, proliferative activity of EPCs was assessed using MTT assay. CM-DiI was used to trace EPCs in vivo 4 days after injection of 5 x 10(5) VEGF-transduced EPCs(VEGF-transduced EPCs group, n = 10), 5 x 10(5) EPCs (non-transduced EPCs group, n = 10) in 500 microL EBM-2 media, or 500 microL EBM-2 media (EBM-2 media group, n = 10) local, a cranially based flap was elevated on the back of nude mice. The percent flap survival, neovasculariztion and blood flow recovery of flaps was detected. RESULTS EPCs expressed cell markers CD34, KDR, and CD133. A statistically significant increase in percent flap survival was observed in mice of VEGF-transduced EPCs group as compared with that of non-transduced EPCs group: 67.99 +/- 6.64% versus 59.43 +/- 4.69% (P < 0.01), and 41.24 +/- 2.44% in EBM-2 media group (P < 0.01). The capillary density and blood flow recovery of flaps in VEGF-transduced EPCs group were both improved. CM-DiI-labeled VEGF-transduced EPCs were observed in vivo and the numbers of cells increased. CONCLUSIONS EPCs from human cord blood can increased neovascularization of ischemic flaps and augmented the survival areas, and VEGF-transduced EPCs have more powerful ability of promoting neovascularization in animal model of ischemic flaps.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell
D013524 Surgical Flaps Tongues of skin and subcutaneous tissue, sometimes including muscle, cut away from the underlying parts but often still attached at one end. They retain their own microvasculature which is also transferred to the new site. They are often used in plastic surgery for filling a defect in a neighboring region. Island Flap,Island Flaps,Flap, Surgical,Flaps, Surgical,Pedicled Flap,Surgical Flap,Flap, Island,Flap, Pedicled,Flaps, Island,Flaps, Pedicled,Pedicled Flaps
D014161 Transduction, Genetic The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE. Genetic Transduction,Genetic Transductions,Transductions, Genetic

Related Publications

Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration.
February 2002, Circulation,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Endothelial progenitor cells for vascular regeneration.
April 2002, Journal of hematotherapy & stem cell research,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
September 2009, Journal of vascular surgery,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
[Effect of nanoparticle with vascular endothelial growth factor gene transferred into ischemic myocardium: experiment with rabbits].
February 2006, Zhonghua yi xue za zhi,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Tissue engineering of bladder using vascular endothelial growth factor gene-modified endothelial progenitor cells.
December 2011, The International journal of artificial organs,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Transplantation of vascular endothelial growth factor 165‑transfected endothelial progenitor cells for the treatment of limb ischemia.
October 2015, Molecular medicine reports,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Cell therapy and gene therapy using endothelial progenitor cells for vascular regeneration.
January 2007, Handbook of experimental pharmacology,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Cell transplantation into ischemic myocardium using mesenchymal stem cells transfected by vascular endothelial growth factor.
January 2014, International journal of clinical and experimental pathology,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects.
June 2000, Circulation research,
Chenggang Yi, and Wei Xia, and Yan Zheng, and Lingxi Zhang, and Maoguo Shu, and Jie Liang, and Yan Han, and Shuzhong Guo
Bone marrow-derived endothelial progenitor cells for vascular regeneration.
August 2002, Current opinion in molecular therapeutics,
Copied contents to your clipboard!